» Articles » PMID: 37060245

Employment Status, Productivity Loss, and Associated Factors Among People with Multiple Sclerosis

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2023 Apr 15
PMID 37060245
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multiple Sclerosis (MS) affects people in their most productive years of life. Consequently, MS can substantially affect employment and work-related outcomes.

Objectives: This study characterizes productivity loss and employment status of people with multiple sclerosis (pwMS) and investigates associated factors.

Methods: We used baseline data collected as part of the Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis (CanProCo). Using the Valuation of Lost Productivity questionnaire, we measured MS-related paid work productivity loss for those employed, productivity losses incurred by those unemployed (i.e. lost employment time), and unpaid work productivity losses for all. A set of sociodemographic, disease, and performance-related factors were investigated using a two-part regression model for productivity loss and a multinomial logistic model for employment status.

Results: From the cohort of 888 pwMS enrolled at baseline (mostly showing mild to moderate disability), 75% were employed, and of those unemployed, 69% attributed their unemployment to health-related issues. Total productivity loss over a 3-month period averaged 64 and 395 hours for those employed and unemployed, respectively. Some factors that affected productivity loss and employment status included use of disease-modifying therapies, fatigue, and performance indicators such as cognitive processing speed.

Conclusion: Productivity loss experienced by employed and unemployed pwMS is substantial. Targeting the identified modifiable factors is likely to improve work productivity and permanence of MS patients in the workforce.

Citing Articles

Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis.

Singer B, Morgan D, Stamm J, Williams A Neurol Ther. 2024; 13(6):1507-1525.

PMID: 39230830 PMC: 11541994. DOI: 10.1007/s40120-024-00654-1.

References
1.
Kobelt G, Langdon D, Jonsson L . The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: The case of multiple sclerosis. Mult Scler. 2018; 25(5):740-749. PMC: 6439950. DOI: 10.1177/1352458518769837. View

2.
Gallehzan N, Khosravi M, Jamebozorgi K, Mir N, Jalilian H, Soleimanpour S . Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing-remitting multiple sclerosis: a systematic review. Health Econ Rev. 2024; 14(1):12. PMC: 10870486. DOI: 10.1186/s13561-024-00478-7. View

3.
Zhang W, Bansback N, Kopec J, Anis A . Measuring time input loss among patients with rheumatoid arthritis: validity and reliability of the Valuation of Lost Productivity questionnaire. J Occup Environ Med. 2011; 53(5):530-6. DOI: 10.1097/JOM.0b013e318218abf1. View

4.
Llorian E, Zhang W, Khakban A, Patten S, Traboulsee A, Oh J . Productivity loss among people with early multiple sclerosis: A Canadian study. Mult Scler. 2022; 28(9):1414-1423. PMC: 9260491. DOI: 10.1177/13524585211069070. View

5.
Ernstsson O, Gyllensten H, Alexanderson K, Tinghog P, Friberg E, Norlund A . Cost of Illness of Multiple Sclerosis - A Systematic Review. PLoS One. 2016; 11(7):e0159129. PMC: 4943600. DOI: 10.1371/journal.pone.0159129. View